ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,750.00
0.01%
S&P ASX All Technology
3,049.90
-0.57%
Brent Oil
82.92
0.65%
US Dollar vs AUD
1.51302
-0.13%
Bitcoin
62,987.92
2.51%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Precigen Inc (PGEN)

  7. Precigen Inc (PGEN) News

PGEN

Precigen (PGEN)

Precigen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PGEN
DateTimeSourceHeadlineSymbolCompany
09/05/202406:05PR Newswire (US)Precigen to Announce First Quarter 2024 Financial Results on May 14th and Host a Conference Call on June 3rd following the Late-breaking Oral Presentation for PRGN-2012 at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
25/04/202400:20PR Newswire (US)Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual MeetingNASDAQ:PGENPrecigen Inc
24/04/202423:00PR Newswire (US)Actym Therapeutics Appoints Thomas Smart as CEONASDAQ:PGENPrecigen Inc
29/03/202407:05PR Newswire (US)Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11thNASDAQ:PGENPrecigen Inc
20/03/202407:05PR Newswire (US)Precigen Reports Full Year 2023 Financial Results and Business UpdatesNASDAQ:PGENPrecigen Inc
19/03/202422:27IH Market NewsUS Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices RetreatNASDAQ:PGENPrecigen Inc
13/03/202407:05PR Newswire (US)Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory PapillomatosisNASDAQ:PGENPrecigen Inc
06/03/202408:05PR Newswire (US)Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19thNASDAQ:PGENPrecigen Inc
28/02/202405:48Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PGENPrecigen Inc
15/02/202408:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PGENPrecigen Inc
15/02/202407:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PGENPrecigen Inc
09/02/202408:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
07/02/202408:05PR Newswire (US)Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:PGENPrecigen Inc
18/01/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PGENPrecigen Inc
17/01/202400:05PR Newswire (US)Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European CommissionNASDAQ:PGENPrecigen Inc
09/01/202400:39Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
09/01/202400:30PR Newswire (US)Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PGENPrecigen Inc
30/12/202309:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PGENPrecigen Inc
19/12/202308:05PR Newswire (US)Precigen to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:PGENPrecigen Inc
30/11/202308:05PR Newswire (US)Precigen to Participate in the JMP Securities Hematology and Oncology SummitNASDAQ:PGENPrecigen Inc
10/11/202309:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PGENPrecigen Inc
10/11/202309:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PGENPrecigen Inc
10/11/202308:55PR Newswire (US)Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical ProgramsNASDAQ:PGENPrecigen Inc
08/11/202308:05PR Newswire (US)Precigen to Participate in the Stifel 2023 Healthcare ConferenceNASDAQ:PGENPrecigen Inc
20/09/202306:05PR Newswire (US)Precigen to Participate in Upcoming Leading Investor and Industry ConferencesNASDAQ:PGENPrecigen Inc
26/08/202309:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
26/08/202309:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
26/08/202309:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
26/08/202309:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
26/08/202308:59Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PGENPrecigen Inc
 Showing the most relevant articles for your search:NASDAQ:PGEN

Your Recent History

BIT
FECOMM
Vontobel Financial Produ...
BIT
P21217
NLBNPIT21217 20241220 28
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved